Form 4: Sharmistha Dubey Reports Acquisition of Dividend Equivalents in Match Group, Inc.
SEC Form 4 Filing
Director Sharmistha Dubey reports acquiring 53 dividend equivalents convertible to common stock in Match Group, Inc. on April 17, 2025.
Summary
- Sharmistha Dubey, a director of Match Group, Inc., filed a Form 4 on April 21, 2025, reporting a transaction.
- On April 17, 2025, Dubey acquired 53 dividend equivalents, which convert into common stock on a one-for-one basis.
- These dividend equivalents accrued on restricted stock units that vest on the earlier of June 21, 2025, or the date of the next Annual Stockholder Meeting of Match Group, Inc. following the grant date, subject to continued service.
- The price of the dividend equivalents was $0.99.
- Following the reported transaction, Dubey directly owns 53 shares of Match Group, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the transaction itself doesn't indicate any particularly positive or negative sentiment. It's a neutral disclosure.
Industry Context
This filing is a routine disclosure of a transaction by a company insider, as required by the SEC. It provides transparency regarding the holdings and transactions of company directors.
Key Dates
| Date | Description |
|---|---|
| 04/17/2025 | Date of transaction: Sharmistha Dubey acquired dividend equivalents. |
| 04/21/2025 | Date of Form 4 filing. |
| 06/21/2025 | Earliest vesting date for restricted stock units on which the dividend equivalents accrued. |
Keywords
Form 4, Match Group, Inc., Dividend Equivalents, Sharmistha Dubey, Director, MTCH, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.